Elsevier

Biological Psychiatry

Volume 24, Issue 2, June 1988, Pages 199-217
Biological Psychiatry

Haloperidol alters rat CNS cholinergic system: Enzymatic and morphological analyses

https://doi.org/10.1016/0006-3223(88)90275-2Get rights and content
Under a Creative Commons license
open archive

Abstract

Chemical and morphological changes in cholinergic marker enzymes, acetylcholinesterase (AChE), and choline acetyltransferase (ChAT) of striatum, hippocampus, and cerebral cortex were studied following haloperidol treatment of rats. After short-term (7–21 days) haloperidol treatment, the levels of both enzymes (AChE and ChAT) were increased in striatum and hippocampus (>25%), but not in cortex. After long-term (+40 days) haloperidol treatment, the level of AChE activity returned to control levels in alt brain areas, whereas the levels of striatal and hippocampal ChAT decreased by 26% and 29%, respectively. No change in levels of both enzymes was detected after acute treatment (single dose) of haloperidol or chronic treatment with either clozapine or imipramine. Morphological analysis of cholinergic neurons and their processes using monoclonal antibody to ChAT showed two types of changes following 40 days of haloperidol treatment. First, parallel to the observed decrease in the levels of ChAT activity there was a visual decrease in the immunoreactivity in neurons as well as in their processes in striatum and hippocampus. Second, there was an apparent reduction in the size and number of stained neurons and their processes. No changes were seen in immunoreactivity after an acute treatment with haloperidol. These results indicate that the chronic haloperidol treatment in rats causes changes in central cholinergic systems that may be relevant to the pathophysiology of schizophrenia and its treatment.

Cited by (0)

We thank Dr. Sukdeb Mukherjce for bis comments on the manuscript and his helpful suggestions, and Mr. Ferdinand Vilim for his assistance in the early phases of this work.